l-carnitine and tmao γ-Butyrobetaine Is a Proatherogenic Intermediate in Gut Microbial Metabolism of to Gut microbe-derived metabolite trimethylamine N-oxide
Gut microbe derived metabolite trimethylamine N oxide activates PERK to drive fibrogenic mesenchymal differentiation ScienceDirect Dietary allicin reduces transformation of L carnitine to TMAO through impact on gut microbiota ScienceDirect The formation of trimethylamine Noxide (TMAO) from dietary lcarnitine Download Scientific Diagram Frontiers Gut Microbiota Dependent Marker TMAO in Promoting Cardiovascular Disease: Inflammation Mechanism, Clinical Prognostic, and Potential as a Therapeutic Target
Pay in 4 interest-free payments of $6.34 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20



